Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
Cureus
|
June 13, 2024
Choroidal Metastasis From Papillary Renal Cell Carcinomas: A Case Report and a Review of the Literature
Shinnosuke Hiruta, Go Kaneko, Yu Miyama, et al.
International Journal of Clinical Oncology
|
July 7, 2025
Factors associated with primary resistance to enfortumab vedotin in previously treated patients with metastatic urothelial carcinoma: a multicenter retrospective study
Daiki Ikarashi, Nozomi Hayakawa, Go Kaneko, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 3, 2026
Impact of Early Relative Dose Intensity on Survival in Patients Receiving Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Japanese Real-World Multicenter Study
Yuki Endo, Yuma Sakura, Go Kaneko, et al.
IJU Case Reports
|
May 5, 2022
Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long-term treatment-free survival with pembrolizumab and axitinib in the KEYNOTE-426 phase III trial of pembrolizumab and axitinib versus sunitinib
Koshiro Nishimoto, Suguru Shirotake, Yu Miyama, et al.
Case Reports in Oncology
|
January 2, 2026
Long-Term Control after Intermittent Reintroduction of Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Case Report
Kenta Fujii, Suguru Shirotake, Shohei Yamamura, et al.
Japanese Journal of Clinical Oncology
|
June 29, 2024
Association between response to enfortumab vedotin and peripheral neuropathy in urothelial carcinoma patients: a multicenter retrospective study
Nozomi Hayakawa, Eiji Kikuchi, Go Kaneko, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2025
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
Maki Todo, Yodo Gatate, Shintaro Nakano, et al.
IJU Case Reports
|
November 7, 2022
Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome
Koshiro Nishimoto, Noriaki Lukas Santo, Masato Yonamine, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 11, 2018
Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study
Kenichi Nakajima, Go Kaneko, Satoru Takahashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 20, 2021
Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study
Kenichi Nakajima, Atsushi Mizokami, Hideyasu Matsuyama, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
Cureus
|
June 13, 2024
Choroidal Metastasis From Papillary Renal Cell Carcinomas: A Case Report and a Review of the Literature
Shinnosuke Hiruta, Go Kaneko, Yu Miyama, et al.
International Journal of Clinical Oncology
|
July 7, 2025
Factors associated with primary resistance to enfortumab vedotin in previously treated patients with metastatic urothelial carcinoma: a multicenter retrospective study
Daiki Ikarashi, Nozomi Hayakawa, Go Kaneko, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 3, 2026
Impact of Early Relative Dose Intensity on Survival in Patients Receiving Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Japanese Real-World Multicenter Study
Yuki Endo, Yuma Sakura, Go Kaneko, et al.
IJU Case Reports
|
May 5, 2022
Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long-term treatment-free survival with pembrolizumab and axitinib in the KEYNOTE-426 phase III trial of pembrolizumab and axitinib versus sunitinib
Koshiro Nishimoto, Suguru Shirotake, Yu Miyama, et al.
Case Reports in Oncology
|
January 2, 2026
Long-Term Control after Intermittent Reintroduction of Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Case Report
Kenta Fujii, Suguru Shirotake, Shohei Yamamura, et al.
Japanese Journal of Clinical Oncology
|
June 29, 2024
Association between response to enfortumab vedotin and peripheral neuropathy in urothelial carcinoma patients: a multicenter retrospective study
Nozomi Hayakawa, Eiji Kikuchi, Go Kaneko, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2025
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
Maki Todo, Yodo Gatate, Shintaro Nakano, et al.
IJU Case Reports
|
November 7, 2022
Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome
Koshiro Nishimoto, Noriaki Lukas Santo, Masato Yonamine, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 11, 2018
Role of bone scan index in the prognosis and effects of therapy on prostate cancer with bone metastasis: Study design and rationale for the multicenter Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index (PROSTAT-BSI) study
Kenichi Nakajima, Go Kaneko, Satoru Takahashi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 20, 2021
Prognosis of patients with prostate cancer and bone metastasis from the Japanese Prostatic Cancer Registry of Standard Hormonal and Chemotherapy Using Bone Scan Index cohort study
Kenichi Nakajima, Atsushi Mizokami, Hideyasu Matsuyama, et al.
Page
of 4